Clinical Trial Update: Study Of Axitinib In Combination With Cisplatin And Capecitabine In Patients With Advanced Gastric Cancer [Phase 1]

View source ↗

Summary

Phase 1 study assessing the safety and preliminary activity of axitinib combined with cisplatin and capecitabine in patients with advanced gastric cancer; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Axitinib (Axitinib)
• CISPLATIN (cisplatin)
• Capecitabine (capecitabine)

Snippet

Sponsor: Pfizer | Conditions: Stomach Neoplasms, Advanced Gastric Cancer | Phase 1 | Status: COMPLETED | Results posted: 2012-03-26